cardiovascular risk factors
Are immunosuppressive therapies used to treat glomerular disease are related to higher cardiovascular risks? A study compared the risks of cardiovascular events in hospital settings among patients with CKD with and hyperkalemia. Do GLP-1 receptor agonists reduce the risk of important clinical outcomes? Can patients without diabetes benefit from them? Does the prevalence of cardiovascular-kidney-metabolic syndrome stages vary by social determinants of health? Freely Filtered looks at the landmark study of finerenone in heart failure with preserved ejection fraction (FINEARTS study). Daprodustat is used to treat anemia in patients with CKD, but can it affect their risk of heart failure hospitalization? The American Heart Association has launched a 4-year plan to improve awareness and treatment of CKM syndrome. Researchers examined how cardiovascular health status differs between men and women with kidney failure. Could SZC use allow for quick and safe initiation and titration of MRAs and long-term optimal dosing for patients with HRrEF? Researchers studied a large pediatric patient cohort on hemodialysis to learn more about cardiovascular risk factors. Semaglutide helped stem kidney function decline in patients with cardiovascular disease plus overweight or obesity. There are few data on whether finerenone-induced change in UACR mediates cardiovascular and kidney failure outcomes. Higher dialysate sodium preserves blood volume and hemodynamic stability but reduces sodium removal. Since the onset of the pandemic, cardiovascular complications have been seen in patients with CKD and COVID-19. In the overall cohort, the 10-year risk of experiencing a cardiovascular event was high: 14.7%; (95% CI, 12.8%-16.8%). Results of the ORAL Surveillance study were recently published in the NEJM in late January 2022. ORAL Surveillance was ... Cardiovascular disease is the leading cause of death among individuals with chronic kidney disease (CKD). Results of ... Noise pollution from transportation may be associated with aggravating some risk factors, leading to increased ... Congenital Heart Disease Does Not Increase COVID-19 Risk, Severity
... A new study evaluated the risk of major cardiovascular events—including acute coronary syndrome, unstable angina, ...